Sequencing
News on NGS technologies, RNA-seq, clinical sequencing, & sample prep in genetics, genomics, and molecular diagnostics.
Qiagen Acquires NGS Analysis Software Firm Genoox for up to $80M
The acquisition is expected to generate $5 million in sales for Qiagen this year and have a neutral impact on the firm's EPS.
Jefferies Upgrades GeneDx to Buy
Analysts at the investment bank are confident that GeneDx can achieve its promised 30 percent volume growth for WGS and WES tests in 2025, despite the underwhelming Q1 results.
Precision oncology company Inocras launched a clinical MRD test last week that uses Ultima's platform to sequence circulating tumor DNA from blood.
Qiagen Q1 Revenues Rise 5 Percent, Beat Estimates
The firm announced that it will seek to initiate an annual dividend and new share repurchase authorization.
Tempus AI Q1 Revenues Rise 75 Percent, Beat Wall Street Expectation
The firm's Genomics revenues increased 89 percent, while Data and Services revenues rose 43 percent year over year.